InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.8857
-0.0343 (-3.73%)
At close: Mar 9, 2026, 4:00 PM EDT
0.8857
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:31 PM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$346,661
Profits / Employee
-$589,566
Market Cap
3.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2024 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2023 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2022 | 13 | 1 | 8.33% | 13 | 0 |
| Jun 30, 2021 | 12 | 0 | - | 12 | 0 |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China Pharma Holdings | 224 |
| IM Cannabis | 95 |
| China SXT Pharmaceuticals | 75 |
| Sunshine Biopharma | 52 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| Shuttle Pharmaceuticals Holdings | 9 |
| Sonoma Pharmaceuticals | 8 |
INM News
- 10 hours ago - InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial - Newsfile Corp
- 2 days ago - InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Newsfile Corp
- 25 days ago - InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Newsfile Corp
- 2 months ago - InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 2 months ago - InMed Announces Results of 2025 Annual General and Special Meeting - Newsfile Corp
- 3 months ago - InMed Provides Update on BayMedica Commercial Business - Newsfile Corp
- 3 months ago - InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 - Newsfile Corp
- 4 months ago - InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update - Newsfile Corp